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Very early mobilisation within 24 hours of stroke results in a less favourable
outcome at 3 monthsSynopsisSummary of: The Avert Trial Collaboration group. Efﬁcacy and
safety of very early mobilisation within 24 h of stroke onset
(AVERT): a randomised controlled trial. Lancet. [1_TD$DIFF]2015;386:46-55.
Question: Does very early mobilisation reduce disability at
3months in stroke survivors?Design: Randomised, controlled trial
with concealed allocation and blinded outcome assessment.
Setting: 56 stroke units in ﬁve countries (Australia, New Zealand,
Malaysia, Singapore, UK). Participants: Patients (aged  18 years)
with ischaemic or haemorrhagic stroke (ﬁrst or recurrent)
admitted to a stroke unit within 24 hours of stroke onset.
Exclusion criteria were: clinically signiﬁcant pre-morbid disability
(modiﬁed Rankin Scale score > 2); early deterioration; direct
admission to intensive care unit; immediate surgery; another
serious medical illness; and being haemodynamically unstable.
Randomisation of 2104 participants allocated 1054 to the very
early mobilisation group and 1050 to a control group. Interven-
tions: The intervention group received very earlymobilisation that
began within 24 hours of stroke onset. Mobilisation focused on
out-of-bed activities such as sitting, standing and walking, and
included at least three additional out-of-bed sessions to usual care.
The interventionwas delivered by physiotherapy and nursing staff.
The dose was guided by a protocol, which was dictated by four
levels of functional ability and adjusted in line with recovery
(titrated). The intervention period lasted 14 days or until discharge
from stroke unit care. The control group received usual stroke unit
care, the components of which, including physiotherapy, were at
the discretion of the individual sites. Outcome measures: The
primary outcome was a favourable outcome (a score of 0 to1836-9553/ 2015 Australian Physiotherapy Association. Published by Elsevier B.V. Al2 representing no orminimumdisability) at 3months after stroke,
measured with the modiﬁed Rankin Scale. The modiﬁed Rankin
Scale is scored between 0 (no disability) [2_TD$DIFF]and 5 (severe disability);
a score of 6 is allocated to those who die. Secondary outcomes
included: time taken to achieve unassistedwalking over 50m; the
proportion of participants achieving unassisted walking by
3 months; and the number of deaths and non-fatal serious
adverse events at 3months.Results: 2083 participants completed
the study. At 3 months, the probability of a favourable modiﬁed
Rankin Scale score was signiﬁcantly less in the intervention group
(OR 0.73, 95% CI 0.59 to [3_TD$DIFF]0.90)when the analysiswas adjusted for age
and National Institutes of Health Stroke Scale score. There was no
signiﬁcant between-group difference in the time taken to achieve
unassisted walking over 50 m (OR 1.04, 95% CI 0.94 to 1.15),[4_TD$DIFF] the
proportionofparticipantsachievingunassistedwalkingby3months
(OR 0.83, 95% CI 0.64 to 1.07), the number of deaths (OR 1.34, 95% CI
0.93 to 1.93) or the proportion of participants who had non-fatal
serious adverse events (OR 0.88, 95% CI 0.72 to 1.07) at 3 months.
Conclusion: Very early mobilisation after stroke reduces the
probability of a favourable outcome at 3 months.
Provenance: Invited. Not peer-reviewed.
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http://dx.doi.org/10.1016/j.jphys.2015.07.010CommentaryThe AVERT trial marks a transformation in stroke rehabilitation
research. For the ﬁrst time[1_TD$DIFF] a simple but crucially important question[2_TD$DIFF]
relevant to the rehabilitation of the majority of stroke patients[3_TD$DIFF] has
been addressed by the international stroke community using robust
trialmethodology. This carefully designed, individually randomised,
controlled trial of very earlymobilisationwas successfully delivered
in56strokeunits inﬁve countries. Therewasa cleardifference in the
intervention parameters between the control and treatment arms:
intervention patients were mobilised sooner, more frequently, and
receivedmore physiotherapy input. It is interesting to note that the
time to ﬁrst mobilisation decreased signiﬁcantly during the study
period for the control group, reﬂecting the shifting context of stroke
unit care over the 8-year recruitment period. The median time to
mobilisationwaswithin 24 hours in both groups (18.5 hours for the
intervention group compared to 22.4 hours for the control group);
this reﬂects practice in participating (and therefore research active)
stroke units which may be atypical of a more general stroke unit
proﬁle. Data collection was robust, with only six patients lost to
follow-up. The results seemclear,with a less favourable outcome for[4_TD$DIFF]
patients in the intervention group who were mobilised very soon
after stroke.More detailed analysiswill provide greater insights and
context to these primary results and inform understanding.The Cochrane Review has highlighted the variability of post-
stroke rehabilitation across the world.1 Uniting to ask clear,
important research questions[5_TD$DIFF], provides a powerful vehicle with
which to drive forward the development and implementation of
the rehabilitation evidence base and improve patient care. There
has been a pleasing increase in large stroke rehabilitation trials,2,3
but AVERT leads the way in demonstrating that such trials can be
implemented internationally. It is important that all in the stroke
community now work together to clearly identify and address the
signiﬁcant questions relating to the rehabilitation of patients after
stroke and evaluate them with similarly robust methods.
Provenance: Invited. Not peer-reviewed.
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